ERTUGLIFLOZIN |
ERTUGLIFLOZIN : Inhibitor of SLC5A2
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| SLC5A2 |
|
Inhibitor
up to 100 nM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Selectivity within target family:
Selective against h-SGLT1 IC50 2050 (>2000 fold)
Potency Cellular
In Vitro
SLC5A2
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1021/jm200049r
In Vivo Validations
Rat
Dose: 2 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
4.1 h
Systemic clearance:
4.04 mL/min/Kg
Volume of Distribution at Steady-State:
1.13 L/Kg
DOI Reference: 10.1021/jm200049r
Dose: 5.0 mg/Kg
Route of delivery:
Oral
Cmax:
1.94 ± 0.185 μg/mL
Tmax:
1.0 h
Bioavailability:
69%
DOI Reference: 10.1021/jm200049r
Chemical Information
| Molecular Formula | C22H25ClO7 |
| SMILEs | CCOc1ccc(Cc2cc([C@]34OC[C@](CO)(O3)[C@@H](O)[C@H](O)[C@H]4O)ccc2Cl)cc1 |
| InChI | InChI=1S/C22H25ClO7/c1-2-28-16-6-3-13(4-7-16)9-14-10-15(5-8-17(14)23)22-20(27)18(25)19(26)21(11-24,30-22)12-29-22/h3-8,10,18-20,24-27H,2,9,11-12H2,1H3/t18-,19-,20+,21-,22-/m0/s1 |
| Molecular weight | 436.13 Da |
| AlogP | 1.3564999999999994 |
| HBond acceptors | 7 |
| HBond donors | 4 |
| Atoms | 55 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.